Dr. Moguilner is researching new neuroimaging biomarkers and machine learning applications for artificial intelligence assisted diagnosis. To reduce the scale and impact of dementia, Dr. Moguilner believes we need to encourage creative solutions to provide new approaches to find early and reliable biomarkers. Dr. Moguilner is developing diagnostic software based on artificial intelligence to enhance our current diagnostic protocols.